Revenue and Profit Growth
Over the seven-year period ending March 2018, Kovai Medical’s net sales expanded significantly, rising from ₹222.19 crores in March 2012 to ₹585.51 crores by March 2018. This represents a robust compound growth trend, reflecting the company’s ability to scale its operations effectively. Total operating income, which includes other operating income, followed a similar pattern, reaching ₹592.37 crores in the latest fiscal year.
Operating profit before depreciation and interest (PBDIT) excluding other income also showed a healthy increase, climbing from ₹44.17 crores in 2012 to ₹129.11 crores in 2018. When factoring in other income, the operating profit rose to ₹136.63 crores in the most recent year. Despite a slight dip in profit before tax from ₹92.43 crores in 2017 to ₹89.44 crores in 2018, the company maintained a strong profit after tax (PAT) of ₹57.98 crores, underscoring its sustained profitability.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
Cost Structure and Margins
Kovai Medical’s cost management has evolved alongside its growth. Raw material costs increased in absolute terms but remained proportionate to revenue expansion. Manufacturing expenses also rose, reflecting increased production activity. Employee costs grew steadily, indicative of workforce expansion to support business operations. Notably, the company reported no selling and distribution expenses, which may suggest a direct sales model or integrated distribution strategy.
Operating profit margins have remained relatively stable, with a slight contraction from 23.53% in 2017 to 21.79% in 2018, still reflecting efficient operational control. Gross profit margins improved markedly over the years, reaching 20.89% in 2018, up from 12.98% in 2012. PAT margins, while fluctuating, showed an overall upward trend, standing at 9.79% in the latest fiscal year.
Balance Sheet Strength and Capitalisation
The company’s balance sheet reveals a strengthening financial position. Shareholders’ funds increased from ₹79.34 crores in 2013 to ₹288.56 crores in 2018, supported by rising reserves. Kovai Medical’s book value per share appreciated significantly, reaching ₹263.71 in 2018 from ₹72.51 in 2013, signalling enhanced shareholder wealth.
Long-term borrowings fluctuated over the years but showed a notable increase to ₹164.56 crores in 2018, reflecting possible investments in capacity expansion or strategic initiatives. Total liabilities rose in tandem with asset growth, with total assets expanding from ₹343.63 crores in 2013 to ₹606.12 crores in 2018. The company maintained a manageable debt profile, with total debt at ₹201.60 crores in 2018.
Cash Flow and Liquidity
Cash flow from operating activities remained positive throughout the period, peaking at ₹99.11 crores in 2017 before moderating to ₹86.88 crores in 2018. Investing activities consistently reflected cash outflows, indicative of ongoing capital expenditure and asset acquisition. Financing activities showed variability, with a significant inflow of ₹59.82 crores in 2018, contrasting with outflows in previous years.
Despite these fluctuations, Kovai Medical maintained a positive net cash inflow in 2018 and improved its closing cash and cash equivalents to ₹23.68 crores, up from ₹17.52 crores the previous year. This suggests prudent liquidity management amid expansion efforts.
Get the full story on Kovai Medical! Our detailed research dives into fundamentals, sector comparison, technical analysis, and valuations for this Hospital Smallcap. Make informed decisions!
- - Full research story
- - Sector comparison done
- - Informed decision support
Summary and Outlook
In summary, Kovai Medical’s historical performance reflects a company on a steady growth path, marked by increasing revenues, improving profitability, and strengthening balance sheet metrics. The firm has successfully managed its cost structure while investing in capacity and maintaining liquidity. Earnings per share have more than quadrupled over the analysed period, underscoring value creation for shareholders.
While the company faces the typical challenges of managing debt and sustaining margins in a competitive sector, its financial discipline and consistent cash flow generation bode well for future prospects. Investors seeking exposure to a growing hospital smallcap may find Kovai Medical’s track record and fundamentals compelling.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
